Helmerich & Payne Inc. Common Stock (HP)
Fast GrowerFairStock Score: 44/100 — MIXED
Key Financials
| Current Price | $39.5 |
| Market Cap | $3.8B |
| P/E Ratio | -10.42 |
| ROE | -12.97% |
| Dividend Yield | 2.67% |
| Sector | Energy |
Strengths
- Generates $359 million in annual free cash flow (9.5% yield on market cap)
- Revenue growth of 50.2% demonstrates strong top-line momentum
- Attractive 2.5% dividend yield providing steady income returns
- Established organization with 15,700 employees providing operational scale
Concerns
- Currently unprofitable—sustained losses could lead to dilutive capital raises or balance sheet deterioration
- Altman Z-Score of 1.5 places it in the financial distress zone—elevated bankruptcy risk
AI Analysis
Helmerich & Payne Inc. Common Stock is a small-cap energy company valued at $3.8 billion. Revenue stands at $4.0 billion, though the company is currently unprofitable. From a quality standpoint, Helmerich shows solid Piotroski F-Score of 6/9 and distressed Altman Z-Score of 1.5 warrants caution. On valuation, the stock is 3.0% FCF yield. Growth dynamics show revenue growing at 50.2% and profit growth of -276.6%. The 2.5% dividend yield adds an income component for patient holders. Our composite FairStock Score of 44/100 reflects below-average fundamentals overall. Without profitability, this remains speculative—suitable only for those with high risk tolerance and a long time horizon.
Bull Case
Helmerich's 50% revenue growth trajectory could accelerate as it captures additional market share in the energy sector. With $359 million in annual free cash flow (9.5% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.
Bear Case
Without a clear path to profitability, continued cash burn forces either dilutive equity raises or debt accumulation that destroys shareholder value. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer